---
title: "LIGAND PHARMACEUTICALS INC COM NEW — Ownership Dossier"
canonical: https://whiteintel.dev/entity/3ba56b03-07d6-54d0-b838-e06a3ced636d
json: https://whiteintel.dev/api/public/dossier/3ba56b03-07d6-54d0-b838-e06a3ced636d
identifier: cusip:53220K504
jurisdiction: US
source: WhiteIntel corporate-ownership graph
---

# LIGAND PHARMACEUTICALS INC COM NEW

**Type:** Asset  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `cusip:53220K504`  
**Canonical dossier:** https://whiteintel.dev/entity/3ba56b03-07d6-54d0-b838-e06a3ced636d  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/3ba56b03-07d6-54d0-b838-e06a3ced636d  

## Ownership & control

### UBO chain (walk to the ultimate owner)

A **1000-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Provenance

- SEC 13F — https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **LIGAND PHARMACEUTICALS INC COM NEW**. Human view: https://whiteintel.dev/entity/3ba56b03-07d6-54d0-b838-e06a3ced636d · Structured JSON: https://whiteintel.dev/api/public/dossier/3ba56b03-07d6-54d0-b838-e06a3ced636d._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._